196 related articles for article (PubMed ID: 26644047)
1. Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.
Yan HM; Song J; Zhang ZH; Jia XB
Drug Deliv; 2016 Oct; 23(8):2911-2918. PubMed ID: 26644047
[TBL] [Abstract][Full Text] [Related]
2. d-α-Tocopheryl polyethylene glycol succinate/Solutol HS 15 mixed micelles for the delivery of baohuoside I against non-small-cell lung cancer: optimization and in vitro, in vivo evaluation.
Yan H; Zhang Z; Jia X; Song J
Int J Nanomedicine; 2016; 11():4563-4571. PubMed ID: 27660448
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.
Yan H; Wei P; Song J; Jia X; Zhang Z
J Pharm Pharmacol; 2016 Oct; 68(10):1290-8. PubMed ID: 27465923
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.
Yan H; Song J; Jia X; Zhang Z
Drug Deliv; 2017 Nov; 24(1):30-39. PubMed ID: 28155337
[TBL] [Abstract][Full Text] [Related]
5. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X
Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers.
Hou J; Wang J; Sun E; Yang L; Yan HM; Jia XB; Zhang ZH
Drug Deliv; 2016 Nov; 23(9):3248-3256. PubMed ID: 26984338
[TBL] [Abstract][Full Text] [Related]
7. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system.
Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH
Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy.
Chu B; Shi S; Li X; Hu L; Shi L; Zhang H; Xu Q; Ye L; Lin G; Zhang N; Zhang X
Int J Pharm; 2016 Nov; 513(1-2):118-129. PubMed ID: 27596115
[TBL] [Abstract][Full Text] [Related]
11. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
13. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
14. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT
Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878
[TBL] [Abstract][Full Text] [Related]
16. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Gill KK; Kaddoumi A; Nazzal S
Eur J Pharm Sci; 2012 May; 46(1-2):64-71. PubMed ID: 22369858
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer.
Jin G; Jin M; Jin Z; Gao Z; Yin X
Oncol Rep; 2016 Aug; 36(2):871-6. PubMed ID: 27279008
[TBL] [Abstract][Full Text] [Related]
18. Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity.
Cheng WJ; Lin SY; Chen M; Chen LC; Ho HO; Chuang KH; Sheu MT
Int J Nanomedicine; 2021; 16():4017-4030. PubMed ID: 34140769
[TBL] [Abstract][Full Text] [Related]
19. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
Huang G; Zang B; Wang X; Liu G; Zhao J
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):981-7. PubMed ID: 26525950
[TBL] [Abstract][Full Text] [Related]
20. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
Chen L; Sha X; Jiang X; Chen Y; Ren Q; Fang X
Int J Nanomedicine; 2013; 8():73-84. PubMed ID: 23319859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
